Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

DNA Analysis of Blood and Tissue From Patients With Lung Cancer

Massachusetts General Hospital · with National Cancer Institute (NCI) · NCT00471978

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–120 · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
15000
US sites recruiting
2
Study start
September 2005
Record last updated
October 7, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help the study of cancer in the future.

PURPOSE: This clinical trial is analyzing the DNA in blood and tissue samples from patients with lung cancer.

Conditions: Lung Cancer

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

DISEASE CHARACTERISTICS

  • Patient:
  • Newly diagnosed primary lung cancer
  • Patient at Massachusetts General Hospital (MGH) or Boston Medical Center Cancer Center

PATIENT CHARACTERISTICS

  • Not specified

PRIOR CONCURRENT THERAPY

  • Not specified

EXCLUSIONS

Vulnerable populations are excluded. Patients with metastasis from another site to lung or mesothelioma are excluded.

Recruiting US locations

  • Massachusetts General Hospital

    Boston, MA 02114

    Site contact: Clinical Trials Office - Massachusetts General Hospital · 877-726-5130

  • Harvard School of Public Health

    Boston, MA 02115

    Site contact: David C. Christiani, MD · 617-726-9274

DNA Analysis of Blood and Tissue From Patients With Lung Cancer (NCT00471978) | Bored Studies